2.5 mg Mounjaro in ml: understanding your starting dose volume

Every 2.5 mg Mounjaro KwikPen contains 2 ml of solution in total, delivering four 0.5 ml weekly doses — one per injection.
The concentration across all Mounjaro strengths is 5 mg/ml, so the ml volume rises predictably as the dose increases.
The pen doses automatically: you press, hold, and the device stops at exactly 0.5 ml. No drawing up, no guessing.
The 2.5 mg dose is a tolerability starter, not the therapeutic target, your prescriber decides if and when titration is appropriate for you.

The 2.5 mg Mounjaro starting dose is delivered in 0.5 ml of solution, pre-loaded into the KwikPen — you don't measure it yourself, and no syringe is involved. That single fixed volume is the same for every 2.5 mg pen; the concentration of tirzepatide in each pen is 5 mg/ml, so the maths is straightforward: 2.5 mg divided by 5 mg/ml equals 0.5 ml. These are prescription-only medicines that a GPhC-registered prescriber must assess you for before any treatment can be dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the 0.5 ml volume means in practice, and what it doesn't

You're holding the pen, wondering what's actually inside it

Picture the moment: the pen arrives, you've read the leaflet twice, and you're still not entirely sure what 2.5 mg actually looks like. It looks like 0.5 ml, roughly half a standard medical millilitre, a tiny amount of clear solution sitting in a cartridge you'll never need to open. The 2.5 mg KwikPen is a multi-dose device containing 2 ml in total, divided into four weekly injections. Each time you press the plunger, the mechanism releases exactly 0.5 ml and stops. There is no dial to set, no graduation mark to hit.

This matters because some people come to Mounjaro having previously used an insulin pen or a different injectable medicine where the user draws up a specific volume. Mounjaro's KwikPen is not that kind of device. The dose is fixed by the pen itself. The NHS's patient guidance on tirzepatide confirms this: your dose is set by the strength of pen prescribed, not by how far you depress it. If you'd like a broader look at how dose volumes work across all Mounjaro strengths, that page walks through the full schedule.

One practical note on timing: if you order at the end of the month (payday orders are common) and you're cutting it close before a holiday weekend, check the cut-off. Orders placed before 12pm on a working day, once clinically approved, are dispatched the same day for next-working-day delivery.

The concentration stays fixed, so converting 2.5 mg to ml is always the same sum

Mounjaro uses a consistent concentration of 5 mg of tirzepatide per millilitre across every strength from 2.5 mg through to 15 mg. That constancy is deliberate: it means the manufacturing process is standardised, and it means you can always cross-check the volume by dividing the dose by five. For 2.5 mg: 2.5 ÷ 5 = 0.5 ml. For the 5 mg dose, the volume is 1.0 ml delivered from a differently loaded pen. Understanding this relationship is useful if you ever read a clinical document or a pharmacist's notes that quote the volume rather than the dose, they're describing the same thing in a different unit.

It's also why the pen sizes change as you move up through the schedule. A 15 mg dose at the same 5 mg/ml concentration would require 3 ml, a larger cartridge than the 2.5 mg version holds. The 5 mg pen's volume is a useful reference point if you're anticipating what the next titration step will feel like physically. Most people report that the injection itself is quick regardless of strength; the volume change is small enough that very few notice a difference between doses.

The NHS's tirzepatide medicine page is worth bookmarking for straightforward, UK-specific guidance on how to use the pen, where to inject, and what to do if a dose is missed, questions that belong with your prescriber or that leaflet, not with a volume calculation.

Why the 2.5 mg dose exists at 0.5 ml rather than starting higher

The starting dose is calibrated for your digestive system, not for weight loss. Tirzepatide slows gastric emptying and changes how your gut signals hunger and fullness, effects that, introduced too quickly, can cause noticeable nausea or discomfort. Beginning at 2.5 mg gives the body four weeks to adjust before any titration decision is made. The volume of 0.5 ml is therefore a function of that tolerability strategy: small enough therapeutically that the effects are gentle at first, fixed by the 5 mg/ml concentration.

NICE's appraisal of tirzepatide, TA1026, notes the licensed schedule starting at 2.5 mg with titration in four-weekly steps as the basis on which the treatment was evaluated, and it's that schedule, not a patient's preference for a higher volume, that the clinical programme was built around. If you feel the 2.5 mg dose isn't doing much after four weeks, that's expected. Raise it with your prescriber. The experience of still feeling hungry at the first dose is common and doesn't mean the medicine isn't working, the adjustment period is real.

For a broader picture of what Mounjaro is, how it works and who it's licensed for, the Mounjaro overview covers the full context. And if you're weighing up the private cost of treatment, the Mounjaro pricing page sets out what to expect from legitimate providers. When you're ready to discuss suitability with a real clinician, our prescribers are available to review your consultation the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions